Literature DB >> 23152493

Heterogeneity of ryanodine receptor dysfunction in a mouse model of catecholaminergic polymorphic ventricular tachycardia.

Randall Loaiza1, Nancy A Benkusky, Patricia P Powers, Timothy Hacker, Sami Noujaim, Michael J Ackerman, José Jalife, Héctor H Valdivia.   

Abstract

RATIONALE: Most cardiac ryanodine receptor (RyR2) mutations associated with catecholaminergic polymorphic ventricular tachycardia (CPVT) are postulated to cause a distinctive form of Ca(2+) release dysfunction. Considering the spread distribution of CPVT mutations, we hypothesized that dysfunctional heterogeneity also was feasible.
OBJECTIVE: To determine the molecular and cellular mechanisms by which a novel RyR2-V2475F mutation associated with CPVT in humans triggers Ca(2+)-dependent arrhythmias in whole hearts and intact mice. METHODS AND
RESULTS: Recombinant channels harboring CPVT-linked RyR2 mutations were functionally characterized using tritiated ryanodine binding and single-channel recordings. Homologous recombination was used to generate a knock-in mouse bearing the RyR2-V2475F mutation. Ventricular myocytes from mice heterozygous for the mutation (RyR2-V2475F(+/-)) and their wild-type littermates were Ca(2+)-imaged by confocal microscopy under conditions that mimic stress. The propensity of wild-type and RyR2-V2475F(+/-) mice to have development of arrhythmias was tested at the whole heart level and in intact animals. Recombinant RyR2-V2475F channels displayed increased cytosolic Ca(2+) activation, abnormal protein kinase A phosphorylation, and increased activation by luminal Ca(2+). The RyR2-V2475F mutation appears embryonic-lethal in homozygous mice, but heterozygous mice have no alterations at baseline. Spontaneous Ca(2+) release events were more frequent and had shorter latency in isoproterenol-stimulated cardiomyocytes from RyR2-V2475F(+/-) hearts, but their threshold was unchanged with respect to wild-type. Adrenergically triggered tachyarrhythmias were more frequent in RyR2-V2475F(+/-) mice.
CONCLUSIONS: The mutation RyR2-V2475F is phenotypically strong among other CPVT mutations and produces heterogeneous mechanisms of RyR2 dysfunction. In living mice, this mutation appears too severe to be harbored in all RyR2 channels but remains undetected under basal conditions if expressed at relatively low levels. β-adrenergic stimulation breaks the delicate Ca(2+) equilibrium of RyR2-V2475F(+/-) hearts and triggers life-threatening arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152493      PMCID: PMC3549355          DOI: 10.1161/CIRCRESAHA.112.274803

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  30 in total

1.  Ryanodine receptor phosphorylation and heart failure: phasing out S2808 and "criminalizing" S2814.

Authors:  Héctor H Valdivia
Journal:  Circ Res       Date:  2012-05-25       Impact factor: 17.367

Review 2.  Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.

Authors:  Silvia G Priori; S R Wayne Chen
Journal:  Circ Res       Date:  2011-04-01       Impact factor: 17.367

3.  Shortened Ca2+ signaling refractoriness underlies cellular arrhythmogenesis in a postinfarction model of sudden cardiac death.

Authors:  Andriy E Belevych; Dmitry Terentyev; Radmila Terentyeva; Hsiang-Ting Ho; Inna Gyorke; Ingrid M Bonilla; Cynthia A Carnes; George E Billman; Sandor Györke
Journal:  Circ Res       Date:  2012-01-05       Impact factor: 17.367

4.  Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor.

Authors:  Nancy A Benkusky; Craig S Weber; Joseph A Scherman; Emily F Farrell; Timothy A Hacker; Manorama C John; Patricia A Powers; Héctor H Valdivia
Journal:  Circ Res       Date:  2007-08-23       Impact factor: 17.367

5.  RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR).

Authors:  Dawei Jiang; Bailong Xiao; Dongmei Yang; Ruiwu Wang; Philip Choi; Lin Zhang; Heping Cheng; S R Wayne Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-20       Impact factor: 11.205

6.  Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.

Authors:  Fredrick A Hilliard; Derek S Steele; Derek Laver; Zhaokang Yang; Sylvain J Le Marchand; Nagesh Chopra; David W Piston; Sabine Huke; Björn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2009-10-14       Impact factor: 5.000

7.  Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak.

Authors:  Stephan E Lehnart; Xander H T Wehrens; Päivi J Laitinen; Steven R Reiken; Shi-Xiang Deng; Zhenzhuang Cheng; Donald W Landry; Kimmo Kontula; Heikki Swan; Andrew R Marks
Journal:  Circulation       Date:  2004-06-14       Impact factor: 29.690

Review 8.  Studying cardiac arrhythmias in the mouse--a reasonable model for probing mechanisms?

Authors:  Jeanne M Nerbonne
Journal:  Trends Cardiovasc Med       Date:  2004-04       Impact factor: 6.677

9.  Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death.

Authors:  N Lowri Thomas; Christopher H George; F Anthony Lai
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

10.  Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Marina Cerrone; Sami F Noujaim; Elena G Tolkacheva; Arkadzi Talkachou; Ryan O'Connell; Omer Berenfeld; Justus Anumonwo; Sandeep V Pandit; Karen Vikstrom; Carlo Napolitano; Silvia G Priori; José Jalife
Journal:  Circ Res       Date:  2007-09-13       Impact factor: 17.367

View more
  30 in total

1.  Sorcin ablation plus β-adrenergic stimulation generate an arrhythmogenic substrate in mouse ventricular myocytes.

Authors:  Xi Chen; Craig Weber; Emily T Farrell; Francisco J Alvarado; Yan-Ting Zhao; Ana M Gómez; Héctor H Valdivia
Journal:  J Mol Cell Cardiol       Date:  2017-11-22       Impact factor: 5.000

2.  Ablation of the cardiac ryanodine receptor phospho-site Ser2808 does not alter the adrenergic response or the progression to heart failure in mice. Elimination of the genetic background as critical variable.

Authors:  Francisco J Alvarado; Xi Chen; Héctor H Valdivia
Journal:  J Mol Cell Cardiol       Date:  2017-01-06       Impact factor: 5.000

3.  The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice.

Authors:  Jingqun Zhang; Biyi Chen; Xiaowei Zhong; Tao Mi; Ang Guo; Qiang Zhou; Zhen Tan; Guogen Wu; Alexander W Chen; Michael Fill; Long-Sheng Song; S R Wayne Chen
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

4.  Genetic ablation of ryanodine receptor 2 phosphorylation at Ser-2808 aggravates Ca(2+)-dependent cardiomyopathy by exacerbating diastolic Ca2+ release.

Authors:  Bin Liu; Hsiang-Ting Ho; Florencia Velez-Cortes; Qing Lou; Carmen R Valdivia; Bjorn C Knollmann; Hector H Valdivia; Sandor Gyorke
Journal:  J Physiol       Date:  2014-01-20       Impact factor: 5.182

5.  Neuronal Na+ channel blockade suppresses arrhythmogenic diastolic Ca2+ release.

Authors:  Przemysław B Radwański; Lucia Brunello; Rengasayee Veeraraghavan; Hsiang-Ting Ho; Qing Lou; Michael A Makara; Andriy E Belevych; Mircea Anghelescu; Silvia G Priori; Pompeo Volpe; Thomas J Hund; Paul M L Janssen; Peter J Mohler; John H B Bridge; Steven Poelzing; Sándor Györke
Journal:  Cardiovasc Res       Date:  2014-12-23       Impact factor: 10.787

6.  Cardiac hypertrophy and arrhythmia in mice induced by a mutation in ryanodine receptor 2.

Authors:  Francisco J Alvarado; J Martijn Bos; Zhiguang Yuchi; Carmen R Valdivia; Jonathan J Hernández; Yan-Ting Zhao; Dawn S Henderlong; Yan Chen; Talia R Booher; Cherisse A Marcou; Filip Van Petegem; Michael J Ackerman; Héctor H Valdivia
Journal:  JCI Insight       Date:  2019-03-05

7.  Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.

Authors:  Yan-Ting Zhao; Carmen R Valdivia; Georgina B Gurrola; Patricia P Powers; B Cicero Willis; Richard L Moss; José Jalife; Héctor H Valdivia
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

8.  Role of RyR2 phosphorylation in heart failure and arrhythmias: Controversies around ryanodine receptor phosphorylation in cardiac disease.

Authors:  Dobromir Dobrev; Xander H T Wehrens
Journal:  Circ Res       Date:  2014-04-11       Impact factor: 17.367

9.  Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy.

Authors:  Adam S Helms; Francisco J Alvarado; Jaime Yob; Vi T Tang; Francis Pagani; Mark W Russell; Héctor H Valdivia; Sharlene M Day
Journal:  Circulation       Date:  2016-09-29       Impact factor: 29.690

10.  Hyperphosphorylation of RyRs underlies triggered activity in transgenic rabbit model of LQT2 syndrome.

Authors:  Dmitry Terentyev; Colin M Rees; Weiyan Li; Leroy L Cooper; Hitesh K Jindal; Xuwen Peng; Yichun Lu; Radmila Terentyeva; Katja E Odening; Jean Daley; Kamana Bist; Bum-Rak Choi; Alain Karma; Gideon Koren
Journal:  Circ Res       Date:  2014-09-23       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.